Sign in
INFI Stock Price, Chart, Stats & News
Infinity Pharmaceuticals, Inc.
Save
Infinity Pharmaceuticals, Inc. (INFI) does not currently pay a dividend.
726,089
Market cap
–
Current P/E
–
Forward P/E
INFI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 39.72% |
Operating margin | -1729.43% |
Pretax margin | -1711.11% |
Net margin | -1668.18% |
Effective tax rate | 2.51% |
ROA | -102.62% |
ROE | -3433.02% |
D/E | -0.05x |
Interest coverage ratio | -249.13x |
INFI valuation
P/E | – |
P/S | 0.28x |
P/B | -0.04x |
P/CF | -0.02x |
P/FCF | -0.02x |
P/OCF | -0.02x |
PEG | -0.00x |
EV multiple | -0.87x |
About
Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549, an experimental immuno-oncology drug taken orally. This candidate, currently in clinical development, functions by blocking the phosphoinositide-3-kinase-gamma enzyme.
Similar securities
Based on sector and market capitalization
Report issue